EMAP — EMAP-Like 4 / Eukaryotic Translation Elongation Factor <table class="infobox infobox-cell">
Overview
flowchart TD
DNA["DNA"] -->|"activates"| CGAS["CGAS"]
DNA["DNA"] -->|"associated with"| GENES["GENES"]
DNA["DNA"] -->|"therapeutic target"| Cancer["Cancer"]
DNA["DNA"] -->|"expressed in"| Als["Als"]
DNA["DNA"] -->|"associated with"| Alzheimer["Alzheimer"]
DNA["DNA"] -->|"associated with"| Als["Als"]
DNA["DNA"] -->|"interacts with"| Tumor["Tumor"]
DNA["DNA"] -->|"inhibits"| Cancer["Cancer"]
DNA["DNA"] -->|"inhibits"| Tumor["Tumor"]
DNA["DNA"] -->|"activates"| Innate_Immunity["Innate Immunity"]
DNA["DNA"] -->|"regulates"| Cancer["Cancer"]
DNA["DNA"] -->|"regulates"| Als["Als"]
DNA["DNA"] -->|"regulates"| Tumor["Tumor"]
DNA["DNA"] -->|"therapeutic target"| Cardiovascular["Cardiovascular"]
style Dna fill:#4fc3f7,stroke:#333,color:#000
...
EMAP — EMAP-Like 4 / Eukaryotic Translation Elongation Factor <table class="infobox infobox-cell">
Overview
Mermaid diagram (expand to render)
EMAP (EMAP-Like 4), also known as EEF1E1 (Eukaryotic Translation Elongation Factor 1 Epsilon 1), is a protein involved in protein synthesis and cell survival pathways. It functions as a component of the eukaryotic translation elongation factor complex and has been implicated in various cellular processes relevant to neurodegeneration.
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000164)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000164)
[OBO Foundry (CL:0000164)](http://purl.obolibrary.org/obo/CL_0000164)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)
Introduction The EMAP gene encodes a protein that, despite its name, is not directly homologous to the original EMAP (endothelial microtubule-associated protein) family. Instead, it participates in translational regulation and has connections to p53-mediated apoptosis pathways. The gene is located on chromosome 6p21.1 [@matsumoto2005].
Structure EMAP/EEF1E1 contains:
Aminoterminal domain : Protein-protein interaction capacitytRNA-binding region : Part of translation elongation functionNuclear localization signals : Implying nuclear functionsp53 interaction domain : Pro-apoptotic signalingCellular Functions
Translation Elongation As part of the eEF1 complex:
Delivers aminoacyl-tRNAs to ribosomes
GTP-dependent elongation cycle
Essential for all protein synthesis
Critical in neurons due to high protein turnover [@browne2002]
Apoptosis Regulation EMAP regulates cell death through:
p53 pathway : Transcriptional activation of pro-apoptotic genesMdm2 interactions : p53 degradation inhibitionBcl-2 family modulation : Mitochondrial apoptosis pathwayCaspase activation : Executioner protease triggeringMitochondrial Function EMAP affects mitochondria:
Modulates mitochondrial membrane potential
Influences respiratory chain function
Affects mitochondrial DNA expression
Controls ATP production
Regulates mitochondrial apoptosis
Role in Neurodegeneration
Alzheimer's Disease
Altered expression in AD brain
May affect tau phosphorylation
Contributes to neuronal apoptosis
Translation dysregulation [@sze2017]
Parkinson's Disease
Modulates dopaminergic neuron survival
Affects alpha-synuclein toxicity
Mitochondrial dysfunction connections
Amyotrophic Lateral Sclerosis (ALS)
Motor neuron apoptosis pathways
Translation dysregulation in disease
Protein aggregation contexts
Huntington's Disease
Transcriptional dysregulation involvement
Mutant huntingtin interactions
Energy metabolism effects
Signal Transduction Pathways EMAP participates in:
p53 signaling : Tumor suppressor and apoptosisATM/ATR DNA damage response c-Myc transcriptional programs Interferon signaling [@liu2010]Therapeutic Implications Targeting EMAP pathways offers:
Apoptosis modulators : Protect neuronsTranslation enhancers : Support protein homeostasisCombination approaches : Multi-target strategiesMitochondrial protectants : Preserve energy metabolism
Biomarkers EMAP as a biomarker:
Detectable in cerebrospinal fluid
Correlates with disease severity
May predict progression
Useful for treatment monitoring
Genetic Associations EMAP polymorphisms studied in:
Cancer risk
Neurodegenerative disease susceptibility
Response to therapy
Metabolic conditions
Research Directions
Structural studies of EMAP complexes
Neuron-specific knockout models
High-throughput screening for modulators
Animal Models Mouse model studies reveal:
Developmental phenotypes
Stress response alterations
Implications for disease understanding
Therapeutic target validation
Future Perspectives Understanding EMAP's multifaceted roles may lead to:
Novel neuroprotective strategies
Biomarkers for neuronal injury
Combination therapy approaches
[Neurons](/cell-types/neurons) Major brain cell type
Glia — Suppor- [Alzheimer's Disease](/diseases/alzheimers-disease)Alzhe- [Parkinson's Disease](/diseases/parkinsons-disease)d neurodegenerative disease
[Parkinson's Disease](/diseases/parkinsons-disease) Related neurodegenerative disease
External Links
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
Pathway Diagram The following diagram shows the key molecular relationships involving Enteroendocrine Cells discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description